• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

NT-pro-BNP 作为标志物可提示心功能障碍,可能由血液透析患者高流量动静脉分流引起。病例报告。

NT-pro-BNP as marker for cardiac strain that may be caused by high-output arteriovenous shunting in a haemodialysis patient. A case report.

机构信息

Department of Public Health and Clinical Medicine, Umea University, SE 90187, Umea, Sweden.

出版信息

BMC Nephrol. 2020 Dec 21;21(1):544. doi: 10.1186/s12882-020-02195-9.

DOI:10.1186/s12882-020-02195-9
PMID:33349246
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7754582/
Abstract

BACKGROUND

An arteriovenous fistula (AVF) is the first choice when considering access for haemodialysis (HD). When a forearm AVF fails an upper arm AVF is a frequent subsequent dialysis access option. The latter may cause cardiac strain. NT-pro-B-type natriuretic peptide (NT-NT-proBNP) is a marker used to estimate volume overload and cardiac strain. This case report shows the benefit of using longitudinal individual follow-up of pre-dialysis NT-proBNP in clinical practice to detect changes in cardiac condition that may be due to high-output AVF.

CASE PRESENTATION

An 18 years old patient performed HD via an upper arm AVF before he was admitted to our unit. NT-proBNP was above the upper detection level of 70,000 ng/L. Echocardiography revealed a left-ventricular cardiac insufficiency. Interdialytic weight gain (IDWG) was above 5%. He was instructed to lower fluid intake and IDWG towards 2%. Four months later NT-proBNP surpassed 70,000 ng/L again. Flow in the brachial artery was at 3034 ml/min. Reconstructive surgery of the AVF did not reduce flow and NT-proBNP in the long run. Clinically, he worsened to NYHA class III-IV. It was decided to close the upper arm AVF and to replace it with a lower arm AVF leading to a reduced artery flow of 1344 mL/min. The clinical condition successively recovered and NT-proBNP decreased to 7000 ng/L.

CONCLUSIONS

Pre-dialysis NT-proBNP should be considered as a suitable routine marker for cardiac strain such as caused by high-output AVF besides variables such as IDWG. Brachial artery flow besides AVF flow measurement is helpful.

摘要

背景

动静脉瘘(AVF)是血液透析(HD)首选的通路。当下肢 AVF 出现故障时,上肢 AVF 是常用的后续透析通路选择。后者可能会导致心脏负担。氨基末端 B 型利钠肽前体(NT-proBNP)是一种用于估计容量超负荷和心脏负担的标志物。本病例报告展示了在临床实践中使用 NT-proBNP 的纵向个体化随访来检测因高流量 AVF 引起的心脏状况变化的益处。

病例介绍

一名 18 岁患者在转入我院前通过上肢 AVF 进行 HD,NT-proBNP 高于 70000ng/L 的检测上限。超声心动图显示左心室心脏功能不全。透析间期体重增加(IDWG)超过 5%。他被指示减少液体摄入和 IDWG 至 2%。四个月后,NT-proBNP 再次超过 70000ng/L。肱动脉血流为 3034ml/min。AVF 的重建手术并不能从长远上降低血流和 NT-proBNP。临床上,他的病情恶化到 NYHA Ⅲ-Ⅳ级。决定关闭上肢 AVF,并更换为下臂 AVF,从而导致动脉血流减少至 1344ml/min。临床状况逐渐恢复,NT-proBNP 降低至 7000ng/L。

结论

除了 IDWG 等变量外,透析前 NT-proBNP 应被视为高流量 AVF 引起的心脏负担等的合适常规标志物。肱动脉血流测量有助于评估 AVF 血流。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05ff/7754582/d0ca6a7a3b9d/12882_2020_2195_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05ff/7754582/33425c5286eb/12882_2020_2195_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05ff/7754582/1bc94f585759/12882_2020_2195_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05ff/7754582/d0ca6a7a3b9d/12882_2020_2195_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05ff/7754582/33425c5286eb/12882_2020_2195_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05ff/7754582/1bc94f585759/12882_2020_2195_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05ff/7754582/d0ca6a7a3b9d/12882_2020_2195_Fig3_HTML.jpg

相似文献

1
NT-pro-BNP as marker for cardiac strain that may be caused by high-output arteriovenous shunting in a haemodialysis patient. A case report.NT-pro-BNP 作为标志物可提示心功能障碍,可能由血液透析患者高流量动静脉分流引起。病例报告。
BMC Nephrol. 2020 Dec 21;21(1):544. doi: 10.1186/s12882-020-02195-9.
2
Brain natriuretic peptide and N-terminal proBNP in chronic haemodialysis patients.慢性血液透析患者中的脑钠肽和N末端前脑钠肽原
Nephron Clin Pract. 2006;103(4):c162-72. doi: 10.1159/000092914. Epub 2006 Apr 25.
3
Neurohormonal and echocardiographic results after CorCap and mitral annuloplasty for dilated cardiomyopathy.扩张型心肌病患者接受CorCap和二尖瓣环成形术后的神经激素及超声心动图结果
Ann Thorac Surg. 2009 Sep;88(3):719-25. doi: 10.1016/j.athoracsur.2009.05.050.
4
Diagnostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for left ventricular dysfunction in patients with chronic kidney disease stage 5 on haemodialysis.N末端B型利钠肽原(NT-proBNP)对慢性肾脏病5期血液透析患者左心室功能障碍的诊断价值
Nephrol Dial Transplant. 2008 Apr;23(4):1370-7. doi: 10.1093/ndt/gfm700. Epub 2007 Dec 18.
5
Effects of Arteriovenous Fistula Ligation on Cardiac Structure and Function in Kidney Transplant Recipients.动静脉瘘结扎对肾移植受者心脏结构和功能的影响。
Circulation. 2019 Jun 18;139(25):2809-2818. doi: 10.1161/CIRCULATIONAHA.118.038505. Epub 2019 May 2.
6
Right Ventricular Enlargement within Months of Arteriovenous Fistula Creation in 2 Hemodialysis Patients.2例血液透析患者动静脉内瘘建立后数月内出现右心室扩大
Tex Heart Inst J. 2016 Aug 1;43(4):350-3. doi: 10.14503/THIJ-15-5353. eCollection 2016 Aug.
7
Prophylactic Ligature of AV Fistula Prevents High Output Heart Failure after Kidney Transplantation.预防性结扎动静脉瘘可预防肾移植后心输出量过高性心力衰竭。
Am J Nephrol. 2020;51(7):511-519. doi: 10.1159/000508957. Epub 2020 Jul 13.
8
N-terminal pro brain natriuretic peptide to predict prognosis in dilated cardiomyopathy with sinus rhythm.N末端脑钠肽前体预测窦性心律扩张型心肌病的预后
Heart Lung Circ. 2007 Aug;16(4):290-4. doi: 10.1016/j.hlc.2007.02.083. Epub 2007 Apr 2.
9
Aminoterminal pro type B natriuretic peptide as a predictive and prognostic marker in patients with chronic heart failure.氨基末端B型利钠肽原作为慢性心力衰竭患者的预测和预后标志物
J Heart Lung Transplant. 2004 Oct;23(10):1189-97. doi: 10.1016/j.healun.2004.07.006.
10
Prohormone brain natriuretic peptide (proBNP), BNP and N-terminal-proBNP circulating levels in chronic hemodialysis patients. Correlation with ventricular function, fluid removal and effect of hemodiafiltration.慢性血液透析患者中前激素脑钠肽(proBNP)、脑钠肽(BNP)和N末端脑钠肽原(NT-proBNP)的循环水平。与心室功能、液体清除的相关性及血液透析滤过的效果
Clin Chem Lab Med. 2008;46(7):1019-24. doi: 10.1515/CCLM.2008.192.

本文引用的文献

1
Early echocardiographic modifications after flow reduction by proximal radial artery ligation in patients with high-output heart failure due to high-flow forearm arteriovenous fistula.高流量前臂动静脉瘘所致高输出量心力衰竭患者近端桡动脉结扎后血流减少的早期超声心动图改变。
J Vasc Access. 2020 Sep;21(5):753-759. doi: 10.1177/1129729820907249. Epub 2020 Feb 27.
2
Intraoperative Ultrasound Guidance for Banding of an Arteriovenous Fistula Causing High Cardiac Output Heart Failure.术中超声引导下对导致高心输出量心力衰竭的动静脉瘘进行绑扎术
Ann Vasc Surg. 2020 Jul;66:665.e5-665.e8. doi: 10.1016/j.avsg.2019.12.011. Epub 2019 Dec 18.
3
Vascular Access Type Was Not Associated with Mortality and the Predictors for Cardiovascular Death in Elderly Chinese Patients on Hemodialysis.
血管通路类型与老年血液透析患者的死亡率无关,心血管死亡的预测因素。
Blood Purif. 2020;49(1-2):63-70. doi: 10.1159/000502941. Epub 2019 Oct 2.
4
Assessment of right heart functions in the patients with arteriovenous fistula for hemodialysis access: Right ventricular free wall strain and tricuspid regurgitation jet velocity as the predictors of right heart failure.血液透析通路动静脉瘘患者右心功能评估:右心室游离壁应变和三尖瓣反流射流速度作为右心衰竭的预测指标。
Vascular. 2020 Feb;28(1):96-103. doi: 10.1177/1708538119866616. Epub 2019 Jul 30.
5
Angiography and phlebography in a hemodialysis population: A retrospective analysis of interventional results.血液透析人群的血管造影和静脉造影:介入治疗结果的回顾性分析。
Int J Artif Organs. 2019 Dec;42(12):675-683. doi: 10.1177/0391398819863429. Epub 2019 Jul 15.
6
A covert complication of arteriovenous fistulas.动静脉瘘的一种隐匿性并发症。
J Cardiol Cases. 2015 Feb 21;11(5):132-135. doi: 10.1016/j.jccase.2015.01.004. eCollection 2015 May.
7
Editorial: High-output state due to an arteriovenous fistula for hemodialysis access as a cause of the aggravation of congestive heart failure.社论:因用于血液透析通路的动静脉瘘导致的心输出量增加状态作为充血性心力衰竭加重的一个原因
J Cardiol Cases. 2015 Apr 2;11(5):136-138. doi: 10.1016/j.jccase.2015.03.002. eCollection 2015 May.
8
Long-Term Survival for Hemodialysis Patients Differ in Japan Versus Europe and the USA. What Might the Reasons Be?日本与欧洲及美国的血液透析患者长期生存率存在差异。原因可能是什么?
Artif Organs. 2018 Dec;42(12):1112-1118. doi: 10.1111/aor.13363. Epub 2018 Nov 11.
9
International Differences in the Location and Use of Arteriovenous Accesses Created for Hemodialysis: Results From the Dialysis Outcomes and Practice Patterns Study (DOPPS).国际间血液透析用动静脉通路位置与使用的差异:来自透析结局和实践模式研究(DOPPS)的结果。
Am J Kidney Dis. 2018 Apr;71(4):469-478. doi: 10.1053/j.ajkd.2017.09.012. Epub 2017 Dec 1.
10
High-Output Heart Failure Revisited.再探高输出量心力衰竭
J Am Coll Cardiol. 2016 Aug 2;68(5):483-486. doi: 10.1016/j.jacc.2016.05.036.